Clinical trials recruiting for NSCLC, Recurrent
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| A2B543 | 1 |
| A2B694 | 1 |
| Atezolizumab | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Arizona | 1 |
| California | 1 |
| Florida | 1 |
| Kansas | 1 |
| Minnesota | 1 |
| Missouri | 1 |
| New York | 1 |
| Ohio | 1 |
| Tennessee | 1 |
| Washington | 1 |
Top cities
Self-screener
Recruiting trials
- A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
- Combination of Atezolizumab and Pirfenidone in Second-line and Beyond NSCLC
- Molecular Landscape Analysis and Clinical Implications for NSCLC Patients With Rare Mutations
Related conditions
Trials recruiting for NSCLC, Recurrent often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for NSCLC, Recurrent trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.